Researchers from the University of Jyväskylä in Finland have found that continued treatment of muscle wasting with a soluble growth factor receptor protein, produced at the University of Helsinki, improved survival in a pre-clinical cancer mouse model...
Original Article: Treating muscle wasting improves cancer survival in mouse model